ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements
Indrayani Biotech announced its Rights Issue of up to 3.25 crore partly paid-up equity shares at ₹15 per share, aggregating to ₹48.79 Crore.
Indrayani Biotech Ltd has revised the schedule for its rights issue. The issue will now be open from September 15, 2026, to October 14, 2026.
Indrayani Biotech Ltd announced the resignation of Mr. K. Ravichandran as its Secretarial Auditor, effective August 6, 2026. The company will appoint a successor in due course.
Indrayani Biotech received approval from the Registrar of Companies to extend the deadline for its FY 2025-26 Annual General Meeting by two months, until November 30, 2026.
Indrayani Biotech Ltd reported revenue from operations of ₹37.8 Cr (-25.3% YoY) and net profit of ₹1 Cr for Q4 FY26.
Indrayani Biotech Ltd reported revenue from operations of ₹72.8 Cr (+43.9% YoY) and net profit of ₹1.1 Cr for Q4 FY26.